• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Fiji Cloudbreak wave ocean surf
Pharma

Midterm blue wave brings pharma and MFN under new scrutiny

Pharma leaders should prepare for scrutiny as a blue wave of federal legislators attempt to pry open Trump's MFN deals.
Donavyn Coffey Nov 12, 2026 2:22pm
Asking More of Science How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Brought to you by Daiichi Sankyo, Inc.
FDA

FDA's CNPV speedy review program, CRL disclosures go quiet

Nov 12, 2026 11:26am
Takeda

Orzeyful gets off to races in US with 'lighter' DEA schedule

Nov 12, 2026 11:16am
Magnifying glass with pills on blue

Regulatory tracker: Lilly nabs 1st China oral obesity drug nod

Nov 12, 2026 9:40am
BMS ESMO Bristol Myers Squibb
Favicon Fierce Biotech

BMS reunites R&D divisions under Massacesi as Plenge departs

Nov 12, 2026 8:16am
More News

PharmaLogic purchases Lantheus' radiopharma CDMO biz, plant

Nov 12, 2026 7:14am

FDA hands out 3 API warning letters after record request snubs

Nov 11, 2026 4:20pm

Legend Biotech drops 16% as soft 2027 outlook tests new CEO

Nov 11, 2026 10:19am
Fierce Biotech

Could we see 10 Chinese Big Pharmas within a decade?

Nov 11, 2026 9:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings